Related Experiment Video
Updated: Jun 25, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Increased proliferation but decreased steroidogenic capacity in Leydig cells from mice lacking cyclin-dependent
Han Lin1, Guo-Xin Hu, Lei Dong
1Population Council and the Rockefeller University, New York, New York, USA.
Abstract:
Proliferating cells express cyclins, cell cycle regulatory proteins that regulate the activity of cyclin-dependent kinases (CDKs). The actions of CDKs are regulated by specific inhibitors, the CDK inhibitors (CDKIs), which are comprised of the Cip/Kip and INK4 families. Expression of the Cip/Kip CDKI 1B (Cdkn1b, encoding protein CDKN1B, also called p27(kip1)) in developing Leydig cells (LCs) has been reported, but the function of CDKN1B in LCs is unclear. The goal of the present study was to determine the effects of CDKN1B on LC proliferation and steroidogenesis by examining these parameters in Cdkn1b knockout (Cdkn1b(-/-)) mice. LC proliferation was measured by bromodeoxyuridine incorporation. Testicular testosterone levels, mRNA levels, and enzyme activities of steroidogenic enzymes were compared in Cdkn1b(-/-) and Cdkn1b(+/+) mice. The labeling index of LCs in Cdkn1b(-/-) mice was 1.5% +/- 0.2%, almost 7-fold higher than 0.2% +/- 0.08% (P < 0.001) in the Cdkn1b(+/+) control mice. LC number per testis in Cdkn1b(-/-) mice was 2-fold that seen in the Cdkn1b(+/+) control mice. However, testicular testosterone levels, mRNA levels of steroidogenic acute regulatory protein (Star), cholesterol side-chain cleavage enzyme (Cyp11a1), and 3beta-hydroxtsteroid dehydrogenase 6 (Hsd3b6), and their respective proteins, were significantly lower in Cdkn1b(-/-) mice. We conclude that deficiency of CDKN1B increased LC proliferation, but decreased steroidogenesis. Thus, CDKN1B is an important regulator of LC development and function.
Insights
Cyclin-dependent kinase inhibitor 1B (CDKN1B) deficiency boosts Leydig cell proliferation but impairs testosterone production. This study reveals CDKN1B
Area of Science:
- Endocrinology
- Cell Biology
- Molecular Biology
Background:
- Cyclins and cyclin-dependent kinases (CDKs) regulate cell proliferation.
- CDK inhibitors (CDKIs) control CDK activity, with Cip/Kip and INK4 families being key.
- The role of Cip/Kip CDKI 1B (CDKN1B) in Leydig cell (LC) function is not well understood.
Purpose of the Study:
- To investigate the impact of CDKN1B on Leydig cell proliferation and steroidogenesis.
- To analyze these effects using a Cdkn1b knockout mouse model (Cdkn1b(-/-)).
Main Methods:
- Assessed Leydig cell proliferation via bromodeoxyuridine incorporation.
- Quantified testicular testosterone levels.
- Measured mRNA and enzyme activity of key steroidogenic enzymes (StAR, CYP11A1, HSD3B6).
Main Results:
- Cdkn1b(-/-) mice exhibited a 7-fold increase in LC proliferation and a 2-fold increase in LC number.
- Testicular testosterone levels were significantly reduced in Cdkn1b(-/-) mice.
- mRNA and protein levels of StAR, CYP11A1, and HSD3B6 were also decreased in knockout mice.
Conclusions:
- CDKN1B deficiency enhances Leydig cell proliferation.
- Loss of CDKN1B function leads to impaired steroidogenesis.
- CDKN1B is a critical regulator of Leydig cell development and function.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
Abnormal Proliferation
Negative Regulator Molecules

